QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
NASDAQ:AVGR

Avinger (AVGR) Stock Forecast, Price & News

$0.56
-0.01 (-1.67%)
(As of 03:08 PM ET)
Compare
Today's Range
$0.55
$0.58
50-Day Range
$0.43
$0.82
52-Week Range
$0.42
$1.95
Volume
15,142 shs
Average Volume
171,279 shs
Market Capitalization
$5.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Avinger MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.47mentions of Avinger in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$181 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.21) to ($0.68) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.50 out of 5 stars


AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com
Avinger Inc AVGR Stock Quote
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)
Avinger: Q1 Earnings Snapshot
Avinger Reports First Quarter 2023 Results
Avinger (NASDAQ:AVGR) Now Covered by StockNews.com
Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
Avinger Reports Fourth Quarter 2022 Results
Avinger Announces 510(k) Filing of Pantheris LV
See More Headlines

AVGR Price History

AVGR Company Calendar

Last Earnings
3/15/2023
Today
6/08/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
71
Year Founded
N/A

Profitability

Net Income
$-17,620,000.00
Net Margins
-207.02%
Pretax Margin
-207.02%

Debt

Sales & Book Value

Annual Sales
$8.27 million
Book Value
$0.56 per share

Miscellaneous

Free Float
10,635,000
Market Cap
$6.02 million
Optionable
Not Optionable
Beta
1.47

Key Executives

  • Mr. Jeffrey M. Soinski (Age 61)
    Pres, CEO & Director
    Comp: $605.15k
  • Mr. Nabeel P. Subainati (Age 39)
    VP of Fin., Principal Financial Officer & Accounting Officer
    Comp: $295.85k
  • Mr. Himanshu N. Patel (Age 63)
    Chief Technology Officer
    Comp: $423.09k
  • Mr. Keith Schaefer
    Chief Operating Officer













AVGR Stock - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

How have AVGR shares performed in 2023?

Avinger's stock was trading at $1.0850 at the beginning of 2023. Since then, AVGR shares have decreased by 48.1% and is now trading at $0.5630.
View the best growth stocks for 2023 here
.

Are investors shorting Avinger?

Avinger saw a drop in short interest in May. As of May 15th, there was short interest totaling 317,000 shares, a drop of 48.6% from the April 30th total of 616,600 shares. Based on an average daily trading volume, of 241,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 3.0% of the company's stock are short sold.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) released its earnings results on Wednesday, March, 15th. The medical device company reported ($0.70) earnings per share for the quarter. The medical device company had revenue of $2 million for the quarter. Avinger had a negative net margin of 207.02% and a negative trailing twelve-month return on equity of 530.21%.

When did Avinger's stock split?

Shares of Avinger reverse split before market open on Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by many different institutional and retail investors. Top institutional shareholders include Armistice Capital LLC (4.38%). Insiders that own company stock include Himanshu Patel, James Cullen, Jeffrey M Soinski, Mark Weinswig and Nabeel Paul Subainati.
View institutional ownership trends
.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.56.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $6.02 million and generates $8.27 million in revenue each year. The medical device company earns $-17,620,000.00 in net income (profit) each year or ($3.12) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -